Aditum Bio

Aditum Bio is an investment company focused on acquiring and developing biotechnology assets that benefit patients. The company was co-founded by industry veterans Joe Jimenez, former CEO of Novartis, Mark Fishman, former President of the Novartis Institutes for BioMedical Research, and Paul Sekhri, former CEO of Lyseira, in collaboration with TrialSpark, a technology-enabled platform that can conduct innovative clinical trials faster and at lower costs compared to traditional Contract Research Organizations (CROs).